Aspen Pharmacare Holdings Ltd
JSE:APN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
9 100
18 324
|
| Price Target |
|
We'll email you a reminder when the closing price reaches Zac.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Operating Margin
Aspen Pharmacare Holdings Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| ZA |
A
|
Aspen Pharmacare Holdings Ltd
JSE:APN
|
43.4B Zac |
3%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
44%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
496.6B USD |
27%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
259.2B CHF |
34%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
212B GBP |
24%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
207B CHF |
33%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
251.4B USD |
38%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
42%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
209B USD |
11%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
143.2B USD |
29%
|
Aspen Pharmacare Holdings Ltd
Glance View
In the vibrant world of global pharmaceuticals, Aspen Pharmacare Holdings Ltd. stands out as a beacon of South African innovation and business acumen. Founded in Durban in 1997, Aspen has grown from modest beginnings into a multinational powerhouse. The company’s core strength lies in manufacturing and producing a diversified portfolio of pharmaceutical products, including generic medications, branded pharmaceuticals, and over-the-counter consumer health products. It further engages in anesthetics, nutritional products, and critical care drugs, offering solutions to myriad health challenges across more than 50 countries. This diversification not only ensures a broad market appeal but effectively hedges against the risks inherent in the pharmaceutical sector, such as patent expirations and regulatory hurdles. Aspen’s financial blueprint is designed around strategic partnerships and manufacturing competencies that serve both developed and emerging markets. It generates revenue primarily through its extensive distribution network and its ability to produce cost-effective generics that address high-demand therapeutic areas, such as cardiovascular, diabetes, and cancer treatments. The company’s growth is fuelled by both organic expansion and astute acquisitions, such as the incorporation of select portfolios from global giants like GlaxoSmithKline. Aspen meticulously balances manufacturing efficiency with stringent regulatory compliance, operated through state-of-the-art facilities accredited by international regulatory bodies. By maintaining this commitment to quality and cost-efficiency, Aspen differentiates itself from competitors and consolidates its position as a significant player in the global pharmaceutical landscape.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Aspen Pharmacare Holdings Ltd's most recent financial statements, the company has Operating Margin of 3.3%.